Vertex (VRTX) EVP/CMO Carmen Bozic Sells 6,988 Shares

What Happened
Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals (VRTX), sold 6,988 shares on 2026-05-12 at $450.00 per share, generating proceeds of $3,144,600. The filing lists the transaction as an open market or private sale.

Key Details

• Transaction date and price: 2026-05-12 — 6,988 shares at $450.00 each. Total proceeds: $3,144,600.
• Filing date: 2026-05-14 (filed within the typical two-business-day window following the trade).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnote: The sale was made pursuant to a company-approved Rule 10b5-1 trading plan entered into on 2025-11-20.
• Transaction code: S = Sale.

Context
Sales executed under 10b5-1 plans are pre-arranged and scheduled, which can indicate routine diversification or liquidity needs rather than a contemporaneous view on the company. For retail investors, purchases generally signal a stronger immediate insider conviction than routine plan-based sales; this filing documents a significant sale but not an explicit change in insider sentiment.